Global law firm Goodwin today announced the launch of its Women’s Health and Wellness practice. This practice builds on decades of women’s health and wellness experience from across the firm’s industries of focus, including private equity, healthcare, technology, life sciences, real estate, and financial institutions. The consolidated offering provides clients with enhanced access to comprehensive legal solutions aimed at disrupting industry-norms, raising critical funding, and improving standards of care. The practice is led by a cross-border, multidisciplinary team, including litigation department chair Joanne Gray, life sciences partners Deepa Rich and Kristopher Brown.
“We are at a turning point in the transformation of healthcare, with the women’s health industry poised to reach $41 billion by 2027,” said Gray. “Our long history of representing clients in the women’s health and wellness ecosystem and our strong focus on convergence across practices have afforded us an unparalleled understanding of the opportunities and challenges presented by this unique market. We look forward to continuing to help clients advance innovation and excellence in this sector, and are privileged to serve as strategic business and legal partners in the improvement of women’s lives around the world.”
The Women’s Health and Wellness practice is an extensive, global network of transactional, regulatory, intellectual property, and litigation lawyers working collaboratively to advise companies and investors across all stages of the corporate lifecycle. Categories of focus within the women’s health and wellness industry include healthcare providers and systems, digital health, femtech, robotics, biotechnology, pharmaceuticals, medical devices, wearables, laboratories, artificial intelligence and machine learning, food and healthy living, cannabis, luxury hotels, supplement and wellness industries, luxury and medi-spas, fintech, and education.
Just a few of the practice’s recent representative matters include Webster Equity Partners’ acquisition of Newborn Advantage Surrogacy, KaNDY Therapeutics’ sale to Bayer, and Johnson & Johnson’s sale of its BabyCenter business to Ziff Davis parent J2 Global.
Learn more about the Women’s Health and Wellness practice.